Moderna (MRNA) Price to Sales (2018 - 2026)
Moderna's (MRNA) quarterly Price to Sales came in at 192.7 in Q2 2026, up 154.96% year-over-year from 75.58 in Q2 2025, and up 271.69% quarter-over-quarter from 51.84 in Q1 2026.
Moderna (MRNA) Price to Sales (2018 - 2026) Analysis & Trends
Moderna (MRNA) has reported Price to Sales for 9 consecutive years, with 192.7 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Price to Sales rose 154.96% year-over-year to 192.7 in Q2 2026; TTM through Jun 2026 was 12.54, a 259.67% increase from a year earlier, with the FY2025 full-year figure at 5.98, up 20.51% from the prior year.
- Price to Sales was 192.7 for Q2 2026 at Moderna, up from 51.84 in the prior quarter.
- Over five years, Price to Sales peaked at 244.39 in Q1 2024 and troughed at 9.94 in Q3 2025.
- A 5-year average of 64.69 and a median of 19.32 in 2025 frame the typical range for Price to Sales.
- Across the five-year window, Price to Sales jumped 1041.24% in 2023 and tumbled 60.05% in 2025, its largest moves.
- Over 5 years, Price to Sales stood at 13.6 in 2022, then retreated by 0.64% to 13.51 in 2023, then gained by 22.94% to 16.61 in 2024, then rose by 3.14% to 17.14 in 2025, then surged by 1024.47% to 192.7 in 2026.
- The last three Price to Sales figures came in at 192.7 (Q2 2026), 51.84 (Q1 2026), and 17.14 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Moderna | 72.66 Bn | 67.52 Bn | 52.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 192.70 |
| Mar 31, 2026 | 51.84 |
| Dec 31, 2025 | 17.14 |
| Sep 30, 2025 | 9.94 |
| Jun 30, 2025 | 75.58 |
| Mar 31, 2025 | 101.59 |
| Dec 31, 2024 | 16.61 |
| Sep 30, 2024 | 13.82 |
| Jun 30, 2024 | 189.21 |
| Mar 31, 2024 | 244.39 |
| Dec 31, 2023 | 13.51 |
| Sep 30, 2023 | 21.49 |
| Jun 30, 2023 | 134.57 |
| Mar 31, 2023 | 31.67 |
| Dec 31, 2022 | 13.60 |
| Sep 30, 2022 | 13.60 |
| Jun 30, 2022 | 11.79 |
| Mar 31, 2022 | 11.36 |
| Dec 31, 2021 | 14.19 |
| Sep 30, 2021 | 31.37 |
Moderna Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();